Virtus Biotech Clinical TriaBBCETF
13F holders, Q4 2025 (December 31)19holders +7
9new positions
2sold out
1famous investor
$39.31avg. 13F price*
At the end of Q4 2025, 19 institutions reported holding Virtus Biotech Clinical Tria (BBC) in their 13F filings, up 7 from Q3 2025. 9 opened new positions and 2 sold out. The largest holders were Kera Capital Partners, Inc. ($3.5M), Citadel Advisors ($1.6M) and Militia Capital Partners, LP ($1.2M). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Virtus Biotech Clinical Tria
- Filed as
- ETFIS SER TR I (Q4 2025)
- CUSIP
- 26923G301
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $6.4M |
| Exits | 2 | $99K |
All 13F filers, Q3 2025 → Q4 2025: 172,929 shares bought and 64,049 shares sold, net +108,880 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 19 holders
| Kera Capital Partners, Inc. | 0.43% | New | 84,970 | $3.5M |
| Citadel Advisors | 0.00% | New | 40,923 | $1.6M |
| Militia Capital Partners, LP | 0.45% | Reduce -41.7% | 31,263 | $1.2M |
| Susquehanna International Group, LLP | 0.00% | Reduce -36.5% | 21,962 | $847K |
| Morgan Stanley | 0.00% | Add +57.0% | 16,859 | $650K |
| MML Investors Services, LLC | 0.00% | New | 14,935 | $576K |
| Envestnet Asset Management Inc. | 0.00% | New | 12,625 | $487K |
| LPL Financial LLC | 0.00% | Reduce -1.2% | 12,315 | $475K |
| Jane Street Group, LLC | 0.00% | Reduce -76.1% | 7,928 | $306K |
| HRT Financial LP | 0.00% | New | 6,085 | $234K |
| UBS Group AG | 0.00% | Add +3945.5% | 4,976 | $192K |
| Group One Trading LLC | 0.00% | New | 1,571 | $61K |
| Dynamic Wealth Strategies, LLC | 0.02% | Add +15.6% | 927 | $36K |
| Osaic Holdings, Inc. | 0.00% | Add +166.3% | 807 | $31K |
| New England Capital Financial Advisors LLC | 0.00% | New | 158 | $6K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 110 | $4K |
| AE Wealth Management LLC | 0.00% | New | 41 | $2K |
| Larson Financial Group LLC | 0.00% | New | 20 | $771 |
| Allworth Financial LP | 0.00% | No change | 10 | $386 |
"% of holder's portfolio" is BBC's weight in each manager's 13F, not the share of Virtus Biotech Clinical Tria the manager owns.